Rafferty Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-214,892
| Closed | -$1M | – | 1157 |
|
|
2024
Q2 | $1M | Sell |
214,892
-638,222
| -75% | -$2.98M | ﹤0.01% | 819 |
|
|
2024
Q1 | $6.33M | Buy |
853,114
+444,049
| +109% | +$3.29M | 0.02% | 413 |
|
|
2023
Q4 | $4.14M | Sell |
409,065
-152,799
| -27% | -$1.55M | 0.02% | 487 |
|
|
2023
Q3 | $4.38M | Sell |
561,864
-80,327
| -13% | -$627K | 0.03% | 414 |
|
|
2023
Q2 | $5.29M | Sell |
642,191
-42,161
| -6% | -$347K | 0.03% | 400 |
|
|
2023
Q1 | $4.96M | Sell |
684,352
-86,600
| -11% | -$628K | 0.03% | 386 |
|
|
2022
Q4 | $6.84M | Buy |
770,952
+333,191
| +76% | +$2.96M | 0.06% | 307 |
|
|
2022
Q3 | $5.36M | Buy |
437,761
+94,662
| +28% | +$1.16M | 0.06% | 324 |
|
|
2022
Q2 | $4.06M | Sell |
343,099
-11,964
| -3% | -$142K | 0.04% | 322 |
|
|
2022
Q1 | $6.75M | Buy |
355,063
+173,292
| +95% | +$3.3M | 0.04% | 285 |
|
|
2021
Q4 | $4.83M | Buy |
181,771
+134,623
| +286% | +$3.57M | 0.03% | 398 |
|
|
2021
Q3 | $1.94M | Sell |
47,148
-22,560
| -32% | -$927K | 0.01% | 644 |
|
|
2021
Q2 | $3.95M | Sell |
69,708
-2,282
| -3% | -$129K | 0.02% | 400 |
|
|
2021
Q1 | $3.02M | Buy |
71,990
+56,935
| +378% | +$2.39M | 0.02% | 488 |
|
|
2020
Q4 | $1.06M | Sell |
15,055
-51,104
| -77% | -$3.58M | 0.01% | 483 |
|
|
2020
Q3 | $1.86M | Buy |
66,159
+32,685
| +98% | +$917K | 0.02% | 441 |
|
|
2020
Q2 | $990K | Buy |
+33,474
| New | +$990K | 0.01% | 546 |
|
|
2020
Q1 | – | Sell |
-49,263
| Closed | -$1.46M | – | 659 |
|
|
2019
Q4 | $1.46M | Sell |
49,263
-65,902
| -57% | -$1.95M | 0.02% | 461 |
|
|
2019
Q3 | $2.62M | Sell |
115,165
-31,188
| -21% | -$709K | 0.04% | 261 |
|
|
2019
Q2 | $3.62M | Buy |
146,353
+5,432
| +4% | +$134K | 0.06% | 228 |
|
|
2019
Q1 | $3.45M | Buy |
+140,921
| New | +$3.45M | 0.06% | 192 |
|